From long‑acting ART to vaccines and curative treatments, innovation is accelerating. Explore ICON’s new HIV whitepaper for insights on breakthrough therapies, including twice-yearly injectable PrEP, vaccines, and curati...
Press releases
-
ICON acquires PMG Research Inc.
Acquisition enhances ICON’s site and patient engagement capabilities.
-
ICON completes acquisition of MediMedia Pharma Solutions
Extends ICON’s leadership in commercialisation and market access services and brings new scientific communications capabilities
-
ICON to acquire MediMedia Pharma Solutions
The acquisition strengthens ICON’s expertise in scientific communications and market access.
